当前位置: 首页 » 论文全文
←返回首页
期刊信息:
《药学服务与研究》2018年, 第18卷, 第6期, 第406-409页
标题:
质子泵抑制剂应用与慢性肾脏病关系的研究进展
DOI:
10.5428/pcar20180603
作者:
1. 程冰封(第二军医大学长海医院肾内科 上海 200433 884015615@qq.com)
2. 谌卫(第二军医大学长海医院肾内科 上海 200433 )
3. 郭志勇(第二军医大学长海医院肾内科 上海 200433 drguozhiyong@163.com)
摘要:
摘要  质子泵抑制剂在临床上应用广泛,本文主要从临床病例研究和病理机制角度阐述质子泵抑制剂与慢性肾脏病之间的关系,对质子泵抑制剂导致肾脏损害及增加慢性肾脏病的风险进行分析,旨在为临床安全用药提供依据。
欢迎阅读《药学服务与研究》!您是该文第 322 位读者!
若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式 程冰封,谌卫,郭志勇. 质子泵抑制剂应用与慢性肾脏病关系的研究进展[J]. 药学服务与研究. 2018; 18(6): 406-409.
英文著录格式 CHENG BingFeng,CHEN Wei,GUO ZhiYong. Research advances in relationship between proton pump inhibitors application and chronic kidney diseases[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(6): 406-409.
参考文献:
1. Nehra A K,Alexander J A,Loftus C G,et al.Proton pump inhibitors:review of emerging concerns[J].Mayo Clin Proc,2018,93(2):240-246.
2. LI TingTing,XIE Yan,Al-Aly Z.The association of proton pump inhibitors and chronic kidney disease:cause or confounding?[J].Curr Opin Nephrol Hypertens,2018,27(3):182-187.
3. Reeve E,Andrews J M,Wiese M D,et al.The feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors[J].Ann Pharmacother,2015,49(1):29-38.
4. 尹钢,张石革.2010-2013年全国医院系统质子泵抑制剂应用趋势及相关问题分析[J].中国医院用药评价与分析,2016,16(6):817-820.
5. Cheungpasitporn W,Thongprayoon C,Kittanamongkolchai W,et al.Proton pump inhibitors linked to hypomagnesemia:a systematic review and meta-analysis of observational studies[J].Ren Fail,2015,37(7):1237-1241.
6. Lambert A A,Lam J O,Paik J J,et al.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy:a systematic review and meta-analysis[J].PLoS One,2015,10(6):e0128004.
7. Gomm W,von Holt K,Thomé F,et al.Association of proton pump inhibitors with risk of dementia:a pharmacoepidemiological claims data analysis[J].JAMA Neurol,2016,73(4):410-416.
8. Zhou B,Huang Y,Li H,et al.Proton-pump inhibitors and risk of fractures:an update meta-analysis[J].Osteoporos Int,2016,27(1):339-347.
9. Tariq R,Singh S,Gupta A,et al.Association of gastric acid suppression with recurrent Clostridium difficile infection:a systematic review and meta-analysis[J].JAMA Intern Med,2017,177(6):784-791.
10. Sierra F,Suarez M,Rey M,et al.Systematic review:proton pump inhibitor-associated acute interstitial nephritis[J].Aliment Pharmacol Ther,2007,26(4):545-553.
11. Blank M L,Parkin L,Paul C,et al.A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use[J].Kidney Int,2014,86(4):837-844.
12. Klepser D G,Collier D S,Cochran G L.Proton pump inhibitors and acute kidney injury:a nested case-control study[J].BMC Nephrol,2013,14:150.
13. Antoniou T,Macdonald E M,Hollands S,et al.Proton pump inhibitors and the risk of acute kidney injury in older patients:a population-based cohort study[J].CMAJ Open,2015,3(2):E166-E171.
14. Lazarus B,CHEN Yuan,Wilson F P,et al.Proton pump inhibitor use and the risk of chronic kidney disease[J].JAMA Intern Med,2016,176(2):238-246.
15. XIE Yan,Bowe B,LI TingTing,et al.Proton pump inhibitors and risk of incident CKD and progression to ESRD[J].J Am Soc Nephrol,2016,27(10):3153-3163.
16. XIE Yan,Bowe B,LI TingTing,et al.Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury[J].Kidney Int,2017,91(6):1482-1494.
17. Peng Y C,LIN ChengLi,Yeh H Z,et al.Association between the use of proton pump inhibitors and the risk of ESRD in renal diseases:a population-based,case control study[J].Medicine,2016,95(15):e3363.
18. Klatte D C F,Gasparini A,XU Hong,et al.Association between proton pump inhibitor use and risk of progression of chronic kidney disease[J].Gastroenterology,2017,153(3):702-710.
19. Hung S C,LIAO KuanFu,Hung H C,et al.Using proton pump inhibitors correlates with an increased risk of chronic kidney disease:a nationwide database-derived case-controlled study[J].Family Pract,2017,35(2):166-171.
20. Wijarnpreecha K,Thongprayoon C,Chesdachai S,et al.Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease:a meta-analysis[J].Dig Dis Sci,2017,62(10):2821-2827.
21. Schneeweiss S.Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics[J].Pharmacoepidemiol Drug Saf,2006,15(5):291-303.
22. Coca S G,Singanamala S,Parikh C R.Chronic kidney disease after acute kidney injury:a systematic review and meta-analysis[J].Kidney Int,2012,81(5):442-448.
23. Hrmark L,van der Wiel H E,de Groot M C,et al.Proton pump inhibitor-induced acute interstitial nephritis[J].Br J Clin Pharmacol,2007,64(6):819-823.
24. Park C H,Kim E H,Roh Y H,et al.The association between the use of proton pump inhibitors and the risk of hypomagnesemia:a systematic review and meta-analysis[J].PLoS One,2014,9(11):e112558.
25. Tin A,Grams M E,Maruthur N M,et al.Results from the atherosclerosis risk in communities study suggest that low serum magnesium is associated with incident kidney disease[J].Kidney Int,2015,87(4):820-827.
26. 于磊,于丽媛,孙鲁宁,等.质子泵抑制剂致肾脏不良反应研究进展[J].中国医院药学杂志,2017,37(16):1649-1652.